The supplement industry is responding to an unprecedented pharmaceutical trend. Current data indicates that 22% of U.S. adults are taking GLP-1 (glucagon-like peptide-1) medications, with an additional 14.5% planning to start. This massive adoption of weight-loss drugs has created urgent demand for complementary nutritional support products that address side effects and long-term metabolic health concerns. […]